The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

EuroIntervention 2015;11:541-548 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_06

1. Cardiovascular Center Aalst, Aalst, Belgium; 2. Clinical Centre Nis, Nis, Serbia; 3. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 4. Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 5. AZ St J

Aims: To report the six-month angiographic and two-year clinical outcome data from the first-in-man study with the Ultimaster DES, a thin-strut cobalt-chromium sirolimus-eluting stent (SE

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Latest news